Medicines UK Chief Executive Mark Samuels says they hope to contribute towards strengthening global partnerships on the critical issues affecting off-patent medicines
Patrick Vallance has been instrumental in turning around international sentiment towards the UK as a life sciences destination, says ABPI's Richard Torbett